Analyst Reco. Fennec Pharmaceuticals Inc.

Equities

FENC

CA31447P1009

Market Closed - Nasdaq Other stock markets 01:30:00 03/05/2024 am IST			5-day change	1st Jan Change
9.09 ^USD	0.00%		-0.76%	-18.98%

23/04	Fennec Pharmaceuticals Insider Sold Shares Worth $414,472, According to a Recent SEC Filing	MT
19/04	Fennec Pharmaceuticals Insider Sold Shares Worth $433,996, According to a Recent SEC Filing	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Fennec Pharmaceuticals Insider Sold Shares Worth $433,996, According to a Recent SEC Filing	19/04	MT
Fennec Pharmaceuticals Insider Sold Shares Worth $457,182, According to a Recent SEC Filing	17/04	MT
Fennec Pharmaceuticals Insider Sold Shares Worth $958,669, According to a Recent SEC Filing	06/04	MT
HC Wainwright Raises Fennec Pharmaceuticals Price Target to $18 From $17, Maintains Buy Rating	04/04	MT
Fennec Pharmaceuticals Insider Sold Shares Worth $437,451, According to a Recent SEC Filing	04/04	MT
HC Wainwright Adjusts Price Target on Fennec Pharmaceuticals to $17 From $18, Maintains Buy Rating	04/23/04	MT
Cantor Fitzgerald Adjusts Fennec Pharmaceuticals' Price Target to $16 From $12	06/23/06	MT
Wedbush Adjusts Fennec Pharmaceuticals Price Target to $16 From $17, Maintains Outperform Rating	30/23/30	MT
Wedbush Lowers Fennec Pharmaceuticals' Price Target to $17 From $19, Maintains Outperform Rating	25/23/25	MT
Cantor Fitzgerald Upgrades Fennec Pharmaceuticals to Overweight From Neutral, Adjusts Price Target to $12 From $9	22/22/22	MT
HC Wainwright Adjusts Fennec Pharmaceuticals' Price Target to $18 From $14, Keeps Buy Rating	20/22/20	MT
Maxim Adjusts Fennec Pharmaceuticals' Price Target to $15 from $10, Maintains Buy	29/22/29	MT
Wedbush Adjusts Fennec Pharmaceuticals Price Target to $19 From $11, Maintains Outperform Rating	26/22/26	MT
Capital One Starts Fennec Pharmaceuticals at Overweight With $11 Price Target	07/22/07	MT
Craig-Hallum Assumes Fennec Pharmaceuticals at Buy With $14 Price Target	08/22/08	MT
Wedbush Maintains Outperform, Raises Fennec Pharmaceuticals' TP to US$11	13/22/13	MT
Wedbush Lifts Price Target for Fennec Pharmaceuticals to $11 From $10, Maintains Outperform Rating	12/22/12	MT
Wedbush Maintains Outperform, US$10 TP on Fennec Pharmaceuticals After Q4, Pedmark Update	01/22/01	MT
Wedbush Lifts Price Target for Fennec Pharmaceuticals to $10 From $9, Maintains Outperform Rating	01/22/01	MT
Maxim Group Adjusts Price Target on Fennec Pharmaceuticals to $10 From $12, Keeps Buy Rating	01/21/01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Fennec Pharmaceuticals Inc.

Equities

FENC

CA31447P1009

Analyst Reco.

Filters